| 5/23/2023 | CV | Market Commentary: Integra LifeSciences convertible notes in focus on product recall; Welltower below par
|
| 5/23/2023 | CV | Market Commentary: Morning Commentary: Integra LifeSciences convertible notes in focus on product recall
|
| 6/1/2022 | CV | Market Commentary: ConMed convertible notes offering eyed; Integra LifeSciences active; Beyond Meat higher
|
| 9/30/2020 | CV | Market Commentary: Convertibles trading quiet; Oasis Petroleum in focus on bankruptcy; Integra gains
|
| 2/24/2020 | CV | Market Commentary: Exact Sciences brings overnight deal; convertibles secondary market weak; Tesla active
|
| 2/18/2020 | CV | Market Commentary: Pegasystems convertible notes, NextEra Energy equity units on tap; Integra improves
|
| 2/7/2020 | CV | Integra LifeSciences greenshoe ups 0.5% convertibles to $575 million
|
| 2/6/2020 | CV | Market Commentary: Smart Global convertibles on tap; PAR expands on debut; Weibo active; Twitter expands
|
| 2/5/2020 | CV | Market Commentary: PAR Technology convertibles eyed; Integra expands on debut; Tesla comes in; Snap expands
|
| 2/5/2020 | CV | Market Commentary: Morning Commentary: Integra hits secondary market; PAR Technology eyed; Snap expands
|
| 2/4/2020 | CV | New Issue: Integra LifeSciences prices $500 million 0.5% 5.5-year convertibles, up 30%
|
| 2/4/2020 | CV | Market Commentary: PAR Technology on tap; Integra convertibles eyed; Tesla’s rise continues; Lumentum up
|
| 2/4/2020 | CV | Market Commentary: Morning Commentary: Integra convertible notes offering eyed; Tesla’s rise continues
|
| 2/4/2020 | CV | Integra LifeSciences pricing $500 million five-year convertibles after Tuesday market close
|
| 2/3/2020 | CV | Market Commentary: Integra convertibles on tap; Tesla ‘a beast’; Luckin Coffee volatile; Insmed expands
|
| 2/3/2020 | CV | Integra LifeSciences talks $500 million five-year convertibles at 0.375%-0.875%, up 27.5%-32.5%
|
| 1/11/2017 | CVLM | Integra tenders for Derma Sciences series A, B convertible preferreds
|
| 4/22/2013 | CV | Market Commentary: Integra LifeSciences flat to lower; Vertex quiet after surge; Intel, Microsoft in trade
|
| 6/4/2012 | BKCV | Integra pays down 2.375% convertibles with revolver borrowings
|
| 6/15/2011 | CV | Integra greenshoe fully exercised, convertibles lifted to $230 million
|
| 6/10/2011 | CV | Market Commentary: Molycorp jumps on debut, but Integra drops; new Brookside extends losses; Vertex expands
|
| 6/10/2011 | CV | New Issue: Integra LifeSciences prices $200 million 5.5-year convertibles at 1.625%, up 23%
|
| 6/9/2011 | CV | Integra LifeSciences to sell $200 million five-year convertibles at 1.25%-1.75%, up 22.5%-27.5%
|
| 6/9/2011 | CV | Market Commentary: Brookdale slips on debut; Forestar scraps deal; Molycorp looks cheap after revised talk
|
| 3/1/2010 | CV | Integra LifeSciences buys back $18.6 million of its 2.75% convertibles
|
| 5/6/2009 | CV | Integra LifeSciences buys back $32.1 million in 2.75% senior convertible notes due 2010
|
| 5/16/2008 | CVDD | Integra to pay penalty interest, damages on 2.75%, 2.375% senior convertibles
|
| 3/5/2008 | CV | Integra Lifesciences secures bank loan needed to repay 2.5% convertibles due 2008
|
| 2/20/2008 | CV | Integra 2.5% convertibles holders to receive contingent interest
|
| 6/11/2007 | CV | Integra greenshoe fully exercised, bringing convertibles to $330 million
|
| 6/6/2007 | CV | Market Commentary: Integra leads new deals with debut gain; Ciena gains dollar-neutral; Dendreon, Cogent set cheaper than talk
|
| 6/6/2007 | CV | New Issue: Integra sells $300 million convertibles: three years at 2.75%, up 27.5%, five years at 2.375%, up 25%
|
| 6/5/2007 | CV | Market Commentary: Amylin gains on debut; Integra higher, Ciena, Dendreon quiet in gray; Cogent, Panda launch unusual deals
|
| 6/4/2007 | CV | Integra to price $250 million three-, five-year convertibles in two tranches Tuesday after close
|
| 6/4/2007 | CV | Market Commentary: Solectron surges on buyout; Amylin flat in gray; Dendreon faces borrow problem; Integra, Ciena plan deals
|
| 10/26/2006 | BTCV | Integra LifeSciences exchanges $4.337 million 2.5% convertibles
|
| 10/2/2006 | BTCV | Integra LifeSciences exchanges $115.205 million 2.5% convertibles
|
| 8/28/2006 | BTCV | Integra LifeSciences prolongs exchange for 2.5% convertibles, adds takeover protection
|
| 8/14/2006 | BTCV | Integra LifeSciences waives minimum participation condition in exchange for 2.5% convertibles
|
| 7/31/2006 | BTCV | Integra LifeSciences modifies net share settlement exchange for 2.5% convertibles
|
| 7/17/2006 | BTCV | Integra LifeSciences begins net share settlement exchange for 2.5% convertibles
|
| 4/11/2003 | CV | Integra says greenshoe exercised, raising convertibles to $120 million
|
| 3/28/2003 | CV | Market Commentary: Continental, Alaska Air dive; Fleming feeds liquidity fears; warnings signal selling spree
|
| 3/26/2003 | CV | New Issue: Integra Lifesciences drive-by $100 million convertibles at 2.5%, up 44.89%
|
| 3/26/2003 | CV | Market Commentary: Integra prices drive-by deal, energy issues spotlighted by $3.3 billion California refunds
|
